vaccines
DomesticBiological Product
Premixed Protamine Recombinant Human Insulin Injection (30/70)
珠海联邦制药股份有限公司中山分公司
Drug Information
| Generic name | 精蛋白重组人胰岛素混合注射液(30/70) |
|---|---|
| Trade name | 优思灵USLIN 30R |
| English name | Premixed Protamine Recombinant Human Insulin Injection (30/70) |
| Dosage form | Injection |
| Specification | 3ml:300国际单位(10.5mg)(笔芯) |
| Category | Biological Product |
| Approval no. | 国药准字S20100013 |
| Drug code | 86900600001233 |
| Manufacturer | 珠海联邦制药股份有限公司中山分公司 |
| Production address | 广东省中山市坦洲镇嘉联路12号 |
| Origin | Domestic |
| Approval date | 2020-04-10 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.